115 related articles for article (PubMed ID: 9228654)
1. Delineation of the border zone of ischemic rabbit myocardium by a technetium-labeled nitroimidazole.
Di Rocco RJ; Bauer AA; Pirro JP; Kuczynski BL; Belnavis L; Chan YW; Linder KE; Narra RK; Nowotnik DP; Nunn AD
Nucl Med Biol; 1997 Apr; 24(3):201-7. PubMed ID: 9228654
[TBL] [Abstract][Full Text] [Related]
2. Myocardial kinetics of a putative hypoxic tissue marker, 99mTc-labeled nitroimidazole (BMS-181321), after regional ischemia and reperfusion.
Stone CK; Mulnix T; Nickles RJ; Renstrom B; Nellis SH; Liedtke AJ; Nunn AD; Kuczynski BL; Rumsey WL
Circulation; 1995 Sep; 92(5):1246-53. PubMed ID: 7648672
[TBL] [Abstract][Full Text] [Related]
3. Ischemic and reperfused myocardium detected with technetium-99m-nitroimidazole.
Fukuchi K; Kusuoka H; Watanabe Y; Fujiwara T; Nishimura T
J Nucl Med; 1996 May; 37(5):761-6. PubMed ID: 8965142
[TBL] [Abstract][Full Text] [Related]
4. Direct detection of regional myocardial ischemia with technetium-99m nitroimidazole in rabbits.
Weinstein H; Reinhardt CP; Leppo JA
J Nucl Med; 1998 Apr; 39(4):598-607. PubMed ID: 9544663
[TBL] [Abstract][Full Text] [Related]
5. SPECT imaging of ischemic myocardium using a technetium-99m-nitroimidazole ligand.
Rumsey WL; Kuczynski B; Patel B; Bauer A; Narra RK; Eaton SM; Nunn AD; Strauss HW
J Nucl Med; 1995 Aug; 36(8):1445-50. PubMed ID: 7629592
[TBL] [Abstract][Full Text] [Related]
6. Imaging of ischemic but viable myocardium using a new 18F-labeled 2-nitroimidazole analog, 18F-FRP170.
Kaneta T; Takai Y; Kagaya Y; Yamane Y; Wada H; Yuki M; Iwata R; Tsujitani M; Takahashi S; Yamada S
J Nucl Med; 2002 Jan; 43(1):109-16. PubMed ID: 11801713
[TBL] [Abstract][Full Text] [Related]
7. Myocardial technetium-99m-teboroxime activity in acute coronary artery occlusion and reperfusion: relation to myocardial blood flow and viability.
Abraham SA; Mirecki FN; Levine D; Nunn AD; Strauss HW; Gewirtz H
J Nucl Med; 1995 Jun; 36(6):1062-8. PubMed ID: 7769429
[TBL] [Abstract][Full Text] [Related]
8. Technetium-99m-nitroimadazole uptake in a swine model of demand ischemia.
Johnson LL; Schofield L; Mastrofrancesco P; Donahay T; Nott L
J Nucl Med; 1998 Aug; 39(8):1468-75. PubMed ID: 9708532
[TBL] [Abstract][Full Text] [Related]
9. 99mTc-tetrofosmin assessment of myocardial perfusion and viability in canine models of coronary occlusion and reperfusion.
Glover DK; Ruiz M; Koplan BA; Watson DD; Beller GA
J Nucl Med; 1999 Jan; 40(1):142-9. PubMed ID: 9935070
[TBL] [Abstract][Full Text] [Related]
10. The potential for myocardial imaging with hypoxia markers.
Sinusas AJ
Semin Nucl Med; 1999 Oct; 29(4):330-8. PubMed ID: 10534235
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the distribution of fluorine-18 fluoromisonidazole, deoxyglucose and methionine in tumour tissue.
Kubota K; Tada M; Yamada S; Hori K; Saito S; Iwata R; Sato K; Fukuda H; Ido T
Eur J Nucl Med; 1999 Jul; 26(7):750-7. PubMed ID: 10398823
[TBL] [Abstract][Full Text] [Related]
12. Kinetic analysis of technetium-99m-labeled nitroimidazole (BMS-181321) as a tracer of myocardial hypoxia.
Ng CK; Sinusas AJ; Zaret BL; Soufer R
Circulation; 1995 Sep; 92(5):1261-8. PubMed ID: 7648674
[TBL] [Abstract][Full Text] [Related]
13. 99mTcO(BAT-NI), a novel nitroimidazole tracer: in vivo uptake studies in ischaemic myocardium.
Hoffend J; Linke G; Mohammed A; Tiefenbacher CP; Eisenhut M; Haberkorn U
Eur J Nucl Med Mol Imaging; 2003 Apr; 30(4):494-501. PubMed ID: 12574972
[TBL] [Abstract][Full Text] [Related]
14. Kinetics of a putative hypoxic tissue marker, technetium-99m-nitroimidazole (BMS181321), in normoxic, hypoxic, ischemic and stunned myocardium.
Kusuoka H; Hashimoto K; Fukuchi K; Nishimura T
J Nucl Med; 1994 Aug; 35(8):1371-6. PubMed ID: 8046496
[TBL] [Abstract][Full Text] [Related]
15. Imaging ischemic tissue at risk of infarction during stroke.
Di Rocco RJ; Kuczynski BL; Pirro JP; Bauer A; Linder KE; Ramalingam K; Cyr JE; Chan YW; Raju N; Narra RK
J Cereb Blood Flow Metab; 1993 Sep; 13(5):755-62. PubMed ID: 8360282
[TBL] [Abstract][Full Text] [Related]
16. Nitroimidazoles for imaging hypoxic myocardium.
Strauss HW; Nunn A; Linder K
J Nucl Cardiol; 1995; 2(5):437-45. PubMed ID: 9420823
[TBL] [Abstract][Full Text] [Related]
17. Stimulated glucose uptake in the ischemic border zone: its dependence on glucose uptake in the normally perfused area.
Yamane Y; Ishide N; Kagaya Y; Takeyama D; Shiba N; Chida M; Nozaki T; Takahashi T; Ido T; Shirato K
J Nucl Med; 1997 Oct; 38(10):1515-21. PubMed ID: 9379185
[TBL] [Abstract][Full Text] [Related]
18. Regional hypoxia correlates with the uptake of a radiolabeled targeted marker of angiogenesis in rat model of myocardial hypertrophy and ischemic injury.
Dobrucki LW; Meoli DF; Hu J; Sadeghi MM; Sinusas AJ
J Physiol Pharmacol; 2009 Oct; 60 Suppl 4():117-23. PubMed ID: 20083860
[TBL] [Abstract][Full Text] [Related]
19. Transmural distribution of 2-deoxyglucose uptake in normal and post-ischemic canine myocardium.
Yoshiyama M; Merkle H; Garwood M; From AH; Bache RJ; Ugurbil K; Zhang J
NMR Biomed; 1995 Feb; 8(1):9-18. PubMed ID: 7547185
[TBL] [Abstract][Full Text] [Related]
20. Technetium-99m-nitroimidazole (BMS181321): a positive imaging agent for detecting myocardial ischemia.
Shi CQ; Sinusas AJ; Dione DP; Singer MJ; Young LH; Heller EN; Rinker BD; Wackers FJ; Zaret BL
J Nucl Med; 1995 Jun; 36(6):1078-86. PubMed ID: 7769431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
